🔗 Permalink

Assignee profile:

CNPHARM CO., LTD.

City:

Seoul

Country:

South Korea

Published Applications:

Last publication date:

2025-07-24

Patent Grants:

Last grant date:

2025-05-13

Top Inventors for applications by CNPHARM CO., LTD.

These are the the leading inventors for applications assigned to CNPHARM CO., LTD.:

Youn Soo Sohn 6 Seoul, South Korea
Yong Joo Jun 6 Seoul, South Korea
Ki-Yeok KIM 4 Seoul, South Korea
Prakash Gouda Avaji 4 Seoul, South Korea

Geun Woo Jin 4 Seoul, South Korea
Ho-jun Kim 4 Seoul, South Korea
Hojun KIM 2 Seoul, South Korea
Sung Mo Choi 1 Seoul, South Korea

Kwang-Sik Park 1 Seoul, South Korea
Guen-Woo Jin 1 Seoul, South Korea

Recent patent applications by CNPHARM CO., LTD.

CNPHARM CO., LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-07-24

US20250235424A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PREPARATION METHOD THEREFOR

#2 | 2025-06-05

US20250177419A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING NICLOSAMIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PREPARATION METHOD THEREFOR

#3 | 2023-06-22 ✅ Patent 12,297,213 granted on 2025-05-13

US20230192726A1

Chemistry; metallurgy

Metal hydroxide complex comprising modified multilayer hydroxide structure comprising active ingredient and method of manufacturing same

#4 | 2023-02-09 ✅ Patent 11,969,440 granted on 2024-04-30

US20230040651A1

Human necessities

Metal (hydr)oxide composite comprising poorly soluble drug, method for manufacturing same, and pharmaceutical composition comprising same

#5 | 2022-10-13 ✅ Patent 12,419,961 granted on 2025-09-23

US20220323589A1

Human necessities

Docetaxel-Aconitic Anhydride conjugate exhibiting anti-tumor activity without in vivo toxicity

#6 | 2022-03-03 ✅ Patent 11,912,829 granted on 2024-02-27

US20220064384A1

Chemistry; metallurgy

Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same

#7 | 2021-10-14 ✅ Patent 12,409,229 granted on 2025-09-09

US20210315998A1

Human necessities

SYNTHESIZING DRUG-ORGANIC-ACID-ANHYDRIDE CONJUGATES WITHOUT USING COUPLING REAGENT

#8 | 2019-09-19 ✅ Patent 10,590,243 granted on 2020-03-17

US20190284346A1

Chemistry; metallurgy

Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same

#9 | 2019-09-19 ✅ Patent 10,584,214 granted on 2020-03-10

US20190284345A1

Chemistry; metallurgy

Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same

#10 | 2017-02-09 ✅ Patent 10,336,867 granted on 2019-07-02

US20170037193A1

Chemistry; metallurgy

Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same

#11 | 2013-10-10

US20130266661A1

Human necessities

AMPHIPHILIC CYCLIC PHOSPHAZENE TRIMER, PHARMACEUTICAL FORMULATION OF HYDROPHOBIC DRUGS BY MICELLE-ENCAPSULATION USING THE AMPHIPHILIC CYCLIC PHOSPHAZENE TRIMER, AND PREPARATION METHODS THEREOF

#12 | 2011-02-24 ✅ Patent 8,344,173 granted on 2013-01-01

US20110046347A1

Human necessities

Dendritic oligopeptide-grafteded cyclotriphosphazene, a process for the preparation thereof and a drug delivery system containing the same

Also check out CNPHARM CO., LTD's (Seoul, South Korea) applicant profile with 14 patent applications submitted.

AssigneeID:

41956 ⎘